Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/2023-505521-14-00
2023-505521-14-00CompletedPhase 1

MK-5684 Food Effect Study

Merck Sharp & Dohme LLC1 site in 1 country14 target enrollmentStarted: July 25, 2023Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Trial Snapshot

Phase
Phase 1
Status
Completed
Enrollment
14
Locations
1
Study OverviewEligibility CriteriaInvestigatorsSitesRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

No summary available.

Eligibility Criteria

Ages
18 years to 64 years (18-64 Years)
Sex
Male
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Investigators

Sponsor Class
Pharmaceutical company
Responsible Party
Principal Investigator
Principal Investigator

Jonathan Belman

Scientific

Merck Sharp & Dohme LLC

Study Sites (1)

Loading locations...

Similar Trials

Active, not recruiting
Phase 1
A Food Effect Study of LY03020 in Healthy SubjectsSchizophrenia
NCT07292233Luye Pharma Group Ltd.16
Completed
Phase 1
NTQ1062 片健康志愿者食物影响研究
CTR2025312628
Completed
Phase 1
A Clinical Trial of MK-1167 in Healthy Adults (MK-1167-010)
NCT07266818Merck Sharp & Dohme LLC30
Recruiting
Phase 1
Evaluation of the Effect of Food, Itraconazole, and Rifampicin on the Single-Dose Pharmacokinetics of Naronapride.
2024-520215-40-00Dr. Falk Pharma GmbH48
Not yet recruiting
Not Applicable
The Effect of Supplementary Foods Containing Trypsin, Chymotrypsin and Serratia Peptidase on Healing After Impacted Wisdom Tooth Surgery
NCT07269171Saglik Bilimleri Universitesi15